Risk factor
Low price volatility
Profitability factor
Strong margins and returns
About
Metropolis Healthcare Limited provides diagnostic services in India. It offers clinical laboratory testing, and profiles and support services. The company provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection,...
Company Valuation
Considering past and projected metrics, the stock is 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITD.
Target Price
The average target price of METROPOLIS.NS is 2223 and suggests 21% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation
Buy
Sell